cagrisema cagrilintide semaglutide phase 3 results 2024 2025 Updates in Medicine | 🔬 REDEFINE 2: in T2D + Obesity Original article link in bio 👥 3a RCT in 1206 adults with T2D (BMI ≥27, HbA1c 7–10%) 💉 Novo Nosedives on Underwhelming CagriSema

Tirzepatide can escalate through two receptor pathways

The most commonly reported issues include nausea (especially during dose increases), gastrointestinal disturbances , reduced sleep quality, elevated resting heart rate (one user noted a 10 bpm increase by week 4), and acid reflux when eating late in the day

Particularly valuable for GLP-1 users who may be training harder than their reduced caloric intake would normally support

Reduces Inflammation in the Scalp: Chronic inflammation around the follicle can lead to hair loss

FDA Disclaimer: CrazyBulk is a dietary supplement and has not been evaluated by the U.S